Pfizer will stop the development of its twice-daily weight loss pill due to adverse side effects.
Share:
More In Business
Big Business This Week: Gobble Gobble Gobbledygook
Was your Thanksgiving dinner cheaper this year? Sources say it should have been! Plus, taxing crypto, Moana gets a sequel, and the french-fry cartel.
Electric Cars Need Recharge as Range Limits, Cost Leave Some Skeptical
While sales of electric vehicles surge in China, the spread of more environmentally friendly vehicles is stumbling in the United States and Europe.
Biden to Loan $6.6 Billion to EV Maker Rivian to Build Paused Factory
President Joe Biden’s administration will loan $6.6 billion to electric vehicle maker Rivian Automotive to build a Georgia factory.
US Consumer Confidence Ticks Higher on Better Outlook for Hiring
Americans’ outlook on the economy improved modestly in November, lifted by expectations for lower inflation and more hiring.
Musk and Trump: How Will The Most Powerful Friendship in the World Affect US Spending?
Simon Shuster, Senior Correspondent at TIME, discusses his recent article, how the friendship between Musk and Trump may affect US spending, “DOGE” and more.
